Delivery Order SPE2DB22D9205-SPE2DB25FZG09
- Not listed
- The Defense Logistics Agency awarded a $1,315.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits, with an ultimate completion date of October 8, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, which...
- The Defense Logistics Agency awarded a $6,579.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 26, 2025, for Mitosol 0.2 mg kits, with an ultimate completion date of October 20, 2025. This delivery order was issued without a set-aside designation and represents a continuation of the agency's ongoing pharmaceutical supply needs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime...
- The Defense Logistics Agency awarded a $7,894.80 delivery order to DMS Pharmaceutical Group Inc. on September 23, 2025, for Mitosol 0.2 mg kits, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, holds a significant single-award Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) under the Medical Supply Chain issued a delivery order valued at $7,894.80 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits. The award, made on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at approximately $500 million through...
- The Defense Logistics Agency has awarded a $78,483.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. The contract, issued on September 27, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation. This delivery order represents work performed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,263.24 by the Defense Logistics Agency on August 14, 2025, for the supply of Mitosol 0.2 mg kits. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and carries no set-aside designation. This award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $5,263.24 for Mitosol 0.2 mg kits. The contract, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $5,263.24 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits, with an ultimate completion date of August 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract employs firm fixed-price pricing and represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $10,526.40 for Mitosol 0.2 mg kits. This firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the vendor's Park Ridge facility. The award carries no set-aside designation and is funded through the Medical Supply Chain division of the Department of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $23.6K on September 24, 2025, for the supply of Mitosol 0.2mg kits under a firm fixed-price contract. The award carries an ultimate completion date of October 22, 2025, and involves no set-aside designation. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division, which procures pharmaceutical products to...
- SPE2DB22D9205Indefinite Delivery Contract
- SPE2DB22D9205-SPE2DB25FZG09Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,789.60 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The award was issued on May 12, 2025, with an ultimate completion date of June 3, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities. Mitosol (mitomycin C) is a chemotherapy agent commonly used in ophthalmologic and oncologic applications. As an established supplier in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in delivering specialized pharmaceutical products to Department of Defense healthcare sites nationwide. The company's track record includes distribution of complex medications spanning contraceptive devices, oncology treatments, and various prescription drugs to military medical facilities. This delivery order represents routine procurement activity within DMS Pharmaceutical Group's broader pharmaceutical distribution mission to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 5/12/25 |